USP17L2 and breast cancer: DUB inhibitors like WP1130 promote Snail degradation by targeting Dub3 or USP9X, inhibiting EMT and metastasis in BC while sensitizing TNBC to cisplatin and paclitaxel in vitro and in vivo102, 248.